These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 26837706

  • 1. Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1?
    Alemi M, Gaiteiro C, Ribeiro CA, Santos LM, Gomes JR, Oliveira SM, Couraud PO, Weksler B, Romero I, Saraiva MJ, Cardoso I.
    Sci Rep; 2016 Feb 03; 6():20164. PubMed ID: 26837706
    [Abstract] [Full Text] [Related]

  • 2. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
    Alemi M, Silva SC, Santana I, Cardoso I.
    CNS Neurosci Ther; 2017 Jul 03; 23(7):605-619. PubMed ID: 28570028
    [Abstract] [Full Text] [Related]

  • 3. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA, Oliveira SM, Guido LF, Magalhães A, Valencia G, Arsequell G, Saraiva MJ, Cardoso I.
    J Alzheimers Dis; 2014 Jul 03; 39(2):357-70. PubMed ID: 24169237
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B, Crawford F, Bachmeier C.
    Fluids Barriers CNS; 2016 Aug 08; 13(1):14. PubMed ID: 27503326
    [Abstract] [Full Text] [Related]

  • 5. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
    Guo YX, He LY, Zhang M, Wang F, Liu F, Peng WX.
    Neuroscience; 2016 May 13; 322():28-38. PubMed ID: 26820600
    [Abstract] [Full Text] [Related]

  • 6. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
    Zhou R, Chen LL, Yang H, Li L, Liu J, Chen L, Hong WJ, Wang CG, Ma JJ, Huang J, Zhou XF, Liu D, Zhou HD.
    Curr Alzheimer Res; 2021 May 13; 18(5):428-442. PubMed ID: 34488598
    [Abstract] [Full Text] [Related]

  • 7. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin).
    Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, Saraiva MJ, Sisodia SS.
    J Neurosci; 2007 Jun 27; 27(26):7006-10. PubMed ID: 17596449
    [Abstract] [Full Text] [Related]

  • 8. Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective?
    Li X, Masliah E, Reixach N, Buxbaum JN.
    J Neurosci; 2011 Aug 31; 31(35):12483-90. PubMed ID: 21880910
    [Abstract] [Full Text] [Related]

  • 9. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
    Wati H, Kawarabayashi T, Matsubara E, Kasai A, Hirasawa T, Kubota T, Harigaya Y, Shoji M, Maeda S.
    Brain Pathol; 2009 Jan 31; 19(1):48-57. PubMed ID: 18429966
    [Abstract] [Full Text] [Related]

  • 10. Gender-dependent transthyretin modulation of brain amyloid-β levels: evidence from a mouse model of Alzheimer's disease.
    Oliveira SM, Ribeiro CA, Cardoso I, Saraiva MJ.
    J Alzheimers Dis; 2011 Jan 31; 27(2):429-39. PubMed ID: 21841252
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro.
    Li X, Zhang X, Ladiwala AR, Du D, Yadav JK, Tessier PM, Wright PE, Kelly JW, Buxbaum JN.
    J Neurosci; 2013 Dec 11; 33(50):19423-33. PubMed ID: 24336709
    [Abstract] [Full Text] [Related]

  • 12. Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.
    Qosa H, LeVine H, Keller JN, Kaddoumi A.
    Biochim Biophys Acta; 2014 Sep 11; 1842(9):1806-15. PubMed ID: 24997450
    [Abstract] [Full Text] [Related]

  • 13. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
    Shang J, Yamashita T, Tian F, Li X, Liu X, Shi X, Nakano Y, Tsunoda K, Nomura E, Sasaki R, Tadokoro K, Sato K, Takemoto M, Hishikawa N, Ohta Y, Abe K.
    Brain Res; 2019 Nov 15; 1723():146379. PubMed ID: 31415766
    [Abstract] [Full Text] [Related]

  • 14. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease.
    Van Gool B, Storck SE, Reekmans SM, Lechat B, Gordts PLSM, Pradier L, Pietrzik CU, Roebroek AJM.
    Mol Neurobiol; 2019 Oct 15; 56(10):7234-7245. PubMed ID: 31004319
    [Abstract] [Full Text] [Related]

  • 15. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus.
    P X, Zz L, Gg J, Lp W, Cm B, Yl W, Chen MF, W L.
    Neurochem Int; 2022 Nov 15; 160():105417. PubMed ID: 36067928
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
    Deane R, Bell RD, Sagare A, Zlokovic BV.
    CNS Neurol Disord Drug Targets; 2009 Mar 15; 8(1):16-30. PubMed ID: 19275634
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.